Moreover, our experiments using BALB/c mice have shown that Ba/F3 cells carrying the TERF2::PDGFRB fusion gene are capable of inducing leukaemia in vivo and are notably sensitive to imatinib treatment. Here, TERF2 is linked to leukemia.